32 - State-of-the-ART HIV Care

Monday, October 20, 2025

10:30 AM - 11:45 AM US ET

Location: Thomas B. Murphy Ballroom 2-3

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Moderator(s)

Amesika Nyaku, MD, MS (she/her/hers)

Assistant Professor
Medicine/Infectious Diseases
Northwestern University
Chicago, IL, United States
Shashi Kapadia, MD (he/him/his)

Assistant Professor of Medicine
Weill Cornell Medical Center
New York, NY, United States

Faculty(s)

John Koethe, MD

Associate Professor
Vanderbilt University Medical Center
Nashville, TN, United States
RG

Roy Gulick, MD, MPH (he/him/his)

Professor of Medicine Chief, Division of Infectious Diseases
Weill Cornell Medicine
New York, NY, United States
Sara Bares, MD

Associate Professor, Division of Infectious Diseases
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, NE, United States

Disclosure(s):

Amesika Nyaku, MD, MS: Gilead Biosciences: Grant/Research Support

Shashi N. Kapadia, MD: No financial relationships to disclose.

John R. Koethe, MD: Gilead Sciences: Advisor/Consultant, Grant/Research Support; Merck and Company, Inc.: Advisor/Consultant, Grant/Research Support

Roy Gulick, MD, MPH: No financial relationships to disclose.

Sara H. Bares, MD: Gilead Sciences: Expert Testimony

Learning Objectives:

At the conclusion of this session, participants will be able to:

list the latest antiretroviral drugs approved for HIV treatment;
explain the mechanism of action of new antiretroviral drugs;
identify the efficacy and side effects of new HIV treatments;
recognize the impact of recent advancements in HIV treatment on patient outcomes and public health.

Presentations:

10:30 AM - 10:55 AM US ET

ART 101 in 2025
Speaker: Roy Gulick, MD, MPH (he/him/his) – Weill Cornell Medicine
10:55 AM - 11:20 AM US ET

Implementing Long-Acting ART
Speaker: Sara H. Bares, MD – University of Nebraska Medical Center
11:20 AM - 11:45 AM US ET

Screening and Management of Comorbidities
Speaker: John R. Koethe, MD – Vanderbilt University Medical Center